miRNAs are critical regulators of NLRP3 inflammasome activity (170), and assessing the expression levels of inflammasome-related genes and their regulatory miRNAs may provide a promising diagnostic tool for bladder cancer. This evidence concerns the gene NLRP3 and urinary bladder cancer.